REG - Oxford Nanopore Tech - Notice of Interim Results Presentation

Oxford Nanopore TechnologiesAnnouncement

30/08/2024 14:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240830:nRSd3722Ca&default-theme=true

RNS Number : 3722C  Oxford Nanopore Technologies plc  30 August 2024

 

30 August 2024

Oxford Nanopore Technologies plc

Notice of Interim Results Presentation

Oxford Nanopore Technologies plc (LSE: ONT) ("Oxford Nanopore" or the
"Group"), the company behind a new generation of molecular sensing technology
based on nanopores, will announce its interim results for the six months
ended 30 June 2024, on Tuesday 3 September 2024.

Management will host a virtual presentation on the same day, at 10:00am BST/
5:00am EDT, followed by a Q&A session, accessible via conference call or
webcast. To access the webcast please register via this link
(https://stream.brrmedia.co.uk/broadcast/66be19fcef33bcf5ad291514) . The
webcast will also be available on Oxford Nanopore's website at
https://nanoporetech.com/about-us/investors/reports
(https://nanoporetech.com/about-us/investors/reports) . The same link will
provide access to a replay of the webcast shortly after the event concludes.

Alternatively, please contact OxfordNanoporeTechnologies@teneo.com
(mailto:oxfordnanoporetechnologies@tulchangroup.com) for details of the
conference call.

-Ends-

Enquiries:

 

Investors

ir@nanoporetech.com (mailto:ir@nanoporetech.com)

 

Media

media@nanoporetech.com (mailto:media@nanoporetech.com)

OxfordNanoporeTechnologies@teneo.com
(mailto:OxfordNanoporeTechnologies@teneo.com)

 

About Oxford Nanopore Technologies

Oxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for real-time, high-performance, accessible and scalable analysis of DNA and RNA. The technology is used in more than 120 countries to understand the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses and whole environments.

For more information please visit: www.nanoporetech.com
(http://www.nanoporetech.com)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NORWPUMCRUPCGPU